GRANT SEAN (Chief Financial Officer) purchased 40.1% of their position (14.29K shares) of VERA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $100.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/8/2023ACC: 0001209191-23-007769
Officer· Chief Financial Officer
Since Jul 2021
+14.29K
Net shares
Net buyer
$100.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
14.29K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+14.29K
Price / share
$7.00
Trade value
$100K
% of position
40.1%
2/6/2022
35.65K→49.93K
Total
Net shares
+14.29K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/6/2022 | P · Purchase | +14.29K | $7.00 | $100K | 40.1% | 35.65K | 49.93K |
| Total | +14.29K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Class A Common Stock
IndirectShares owned2.82K
Class A Common Stock
IndirectShares owned992.00
Class A Common Stock
IndirectShares owned857.00
Class A Common Stock
IndirectShares owned335.00
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 2.82K | Indirect |
| Class A Common Stock | 992.00 | Indirect |
| Class A Common Stock | 857.00 | Indirect |
| Class A Common Stock | 335.00 | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported